Literature DB >> 21499735

Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection.

Tatiana Kisseleva1, Maren von Köckritz-Blickwede, Donna Reichart, Shauna M McGillvray, Gerhard Wingender, Mitchell Kronenberg, Christopher K Glass, Victor Nizet, David A Brenner.   

Abstract

Bone marrow (BM)-derived fibrocytes are a population of CD45(+) and collagen Type I-expressing cells that migrate to the spleen and to target injured organs, such as skin, lungs, kidneys, and liver. While CD45(+)Col(+) fibrocytes contribute to collagen deposition at the site of injury, the role of CD45(+)Col(+) cells in spleen has not been elucidated. Here, we demonstrate that hepatotoxic injury (CCl(4)), TGF-β1, lipopolysaccharide, or infection with Listeria monocytogenes induce rapid recruitment of CD45(+)Col(+) fibrocyte-like cells to the spleen. These cells have a gene expression pattern that includes antimicrobial factors (myleoperoxidase, cathelicidin, and defensins) and MHC II at higher levels than found on quiescent or activated macrophages. The immune functions of these splenic CD45(+)Col(+) fibrocyte-like cells include entrapment of bacteria into extracellular DNA-based structures containing cathelicidin and presentation of antigens to naïve CD8(+) T cells to induce their proliferation. Stimulation of these splenic fibrocyte-like cells with granulocyte macrophage-colony stimulating factor or macrophage-colony stimulating factor induces downregulation of collagen expression and terminal differentiation into the dendritic cells or macrophage. Thus, splenic CD45(+)Col(+) cells are a population of rapidly mobilized BM-derived fibrocyte-like cells that respond to inflammation or infection to participate in innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499735      PMCID: PMC3171633          DOI: 10.1007/s00109-011-0756-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  41 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

3.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

Review 4.  Development of neutrophil granule diversity.

Authors:  N Borregaard
Journal:  Ann N Y Acad Sci       Date:  1997-12-15       Impact factor: 5.691

5.  Innate antimicrobial peptide protects the skin from invasive bacterial infection.

Authors:  V Nizet; T Ohtake; X Lauth; J Trowbridge; J Rudisill; R A Dorschner; V Pestonjamasp; J Piraino; K Huttner; R L Gallo
Journal:  Nature       Date:  2001-11-22       Impact factor: 49.962

6.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  Bone marrow-derived progenitor cells in pulmonary fibrosis.

Authors:  Naozumi Hashimoto; Hong Jin; Tianju Liu; Stephen W Chensue; Sem H Phan
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

8.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

10.  Peritoneal repairing cells: a type of bone marrow derived progenitor cells involved in mesothelial regeneration.

Authors:  R Carmona; E Cano; E Grueso; A Ruiz-Villalba; T K Bera; J Gaztambide; J C Segovia; R Muñoz-Chápuli
Journal:  J Cell Mol Med       Date:  2010-05-14       Impact factor: 5.310

View more
  26 in total

1.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

2.  JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.

Authors:  Jingyin Yan; Zhengmao Zhang; Jun Yang; William E Mitch; Yanlin Wang
Journal:  J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 10.121

3.  Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis.

Authors:  Jean A Nemzek; Christopher Fry; Bethany B Moore
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

4.  Origin of stem cells in the BM niche: new clues from mastocytosis.

Authors:  Krisztian Nemeth; Eva Mezey
Journal:  Blood       Date:  2016-02-11       Impact factor: 22.113

Review 5.  Molecular and cellular mechanisms of liver fibrosis and its regression.

Authors:  Tatiana Kisseleva; David Brenner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-30       Impact factor: 46.802

Review 6.  Bone marrow-derived fibrocytes contribute to liver fibrosis.

Authors:  Jun Xu; Tatiana Kisseleva
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

7.  Phagocytosis by Fibrocytes as a Mechanism to Decrease Bacterial Burden and Increase Survival in Sepsis.

Authors:  Dalis Collins; Christopher Fry; Bethany B Moore; Jean A Nemzek
Journal:  Shock       Date:  2019-04       Impact factor: 3.454

Review 8.  Fibrocytes: emerging effector cells in chronic inflammation.

Authors:  Hong Peng; Erica L Herzog
Journal:  Curr Opin Pharmacol       Date:  2012-03-30       Impact factor: 5.547

9.  Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Authors:  Tania Afroj; Atsushi Mitsuhashi; Hirokazu Ogino; Atsuro Saijo; Kenji Otsuka; Hiroto Yoneda; Makoto Tobiume; Na Thi Nguyen; Hisatsugu Goto; Kazuya Koyama; Masamichi Sugimoto; Osamu Kondoh; Hiroshi Nokihara; Yasuhiko Nishioka
Journal:  J Immunol       Date:  2021-01-27       Impact factor: 5.422

10.  Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2.

Authors:  Hendrik W van Deventer; Daniela A Palmieri; Qing Ping Wu; Everett C McCook; Jonathan S Serody
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.